Savanna Biedermann

Cancer Prevention Institute of California

Also affiliated with Stanford Cancer Institute

MedicineEnvironmental Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Phase I/IIa clinical trial of a small molecule EBNA1 inhibitor, VK-2019, in patients with Epstein Barr virus–positive nasopharyngeal cancer with pharmacokinetic and pharmacodynamic correlative studies.”.

Phase I/IIa clinical trial of a small molecule EBNA1 inhibitor, VK-2019, in patients with Epstein Barr virus–positive nasopharyngeal cancer with pharmacokinetic and pharmacodynamic correlative studies.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.6035

N/A

0DataRank · unranked

4 citations

Michelle A. Rudek, Caroline Even, Victor Lee, Maura L. Gillison, Saad A. Khan +6 more